Theravent hits milestone in sleep disorder treatment
SAN JOSE, Calif. – Theravent’s sleep apnea treatments have now been used for more than 4.5 million nights, the company announced Oct. 29. Theravent’s Provent Sleep Apnea Therapy and Theravent Advanced Nightly Snore Therapy use expiratory positive airway pressure to treat obstructive sleep apnea (OSA) and snoring. The machines cover a person’s nostrils to create pressure as the person exhales, keeping the airway open. “We’re pleased to see these therapies helping people around the world by treating conditions that have been linked to serious health problems, such as high blood pressure, stroke and heart attack,” stated Matt Williams, Theravent CEO, in a press release. Theravent says its products are less invasive and more portable than CPAP machines.